KRAS mutation could also enhance the recycling of PD-L1 molecules in pancreatic cancer cells to the cell surface to promote the immune escape of pancreatic cancer cells (Hashimoto et al., 2019). The gene discussed is KRAS; the disease is familial pancreatic carcinoma.